Cargando…
Moxifloxacin-Induced Thrombocytopenia Mediated by Moxifloxacin-Dependent IgM and IgG Antiplatelet Antibodies: A Case Report
Moxifloxacin is a rare but important cause of drug-induced immune thrombocytopenia (DIT). We describe a patient who presented with an acute onset of severe thrombocytopenia complicated by petechial rash, epistaxis, and melena. Recent new drug exposures included moxifloxacin and two proton pump inhib...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571590/ https://www.ncbi.nlm.nih.gov/pubmed/33094048 http://dx.doi.org/10.7759/cureus.10507 |
_version_ | 1783597198784593920 |
---|---|
author | Moore, Joel Baer, Maria R Grover, Brian E Aster, Richard H Millstein, Leah S |
author_facet | Moore, Joel Baer, Maria R Grover, Brian E Aster, Richard H Millstein, Leah S |
author_sort | Moore, Joel |
collection | PubMed |
description | Moxifloxacin is a rare but important cause of drug-induced immune thrombocytopenia (DIT). We describe a patient who presented with an acute onset of severe thrombocytopenia complicated by petechial rash, epistaxis, and melena. Recent new drug exposures included moxifloxacin and two proton pump inhibitors. On presentation to the hospital, all recently initiated medications were discontinued and the patient’s thrombocytopenia was treated with platelet transfusions, intravenous immunoglobulin, and high-dose corticosteroids. Her thrombocytopenia improved over the next seven days and she was discharged on hospital day 8. Serologic testing revealed strongly positive moxifloxacin-dependent IgM and IgG antiplatelet antibodies, confirming a diagnosis of moxifloxacin-induced immune thrombocytopenia. DIT has been reported with other fluoroquinolone antibiotics, especially ciprofloxacin. This case documents a rare but potentially fatal complication of exposure to moxifloxacin and is the first to demonstrate objective evidence of acute sensitization with IgM antibody positivity. It highlights the need to consider this potential reaction when choosing antibiotic therapy, particularly in patients who are at high risk for bleeding, have hematologic disorders, or are receiving myelosuppressive therapies, and perhaps in those with a history of multiple drug allergies. |
format | Online Article Text |
id | pubmed-7571590 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-75715902020-10-21 Moxifloxacin-Induced Thrombocytopenia Mediated by Moxifloxacin-Dependent IgM and IgG Antiplatelet Antibodies: A Case Report Moore, Joel Baer, Maria R Grover, Brian E Aster, Richard H Millstein, Leah S Cureus Internal Medicine Moxifloxacin is a rare but important cause of drug-induced immune thrombocytopenia (DIT). We describe a patient who presented with an acute onset of severe thrombocytopenia complicated by petechial rash, epistaxis, and melena. Recent new drug exposures included moxifloxacin and two proton pump inhibitors. On presentation to the hospital, all recently initiated medications were discontinued and the patient’s thrombocytopenia was treated with platelet transfusions, intravenous immunoglobulin, and high-dose corticosteroids. Her thrombocytopenia improved over the next seven days and she was discharged on hospital day 8. Serologic testing revealed strongly positive moxifloxacin-dependent IgM and IgG antiplatelet antibodies, confirming a diagnosis of moxifloxacin-induced immune thrombocytopenia. DIT has been reported with other fluoroquinolone antibiotics, especially ciprofloxacin. This case documents a rare but potentially fatal complication of exposure to moxifloxacin and is the first to demonstrate objective evidence of acute sensitization with IgM antibody positivity. It highlights the need to consider this potential reaction when choosing antibiotic therapy, particularly in patients who are at high risk for bleeding, have hematologic disorders, or are receiving myelosuppressive therapies, and perhaps in those with a history of multiple drug allergies. Cureus 2020-09-17 /pmc/articles/PMC7571590/ /pubmed/33094048 http://dx.doi.org/10.7759/cureus.10507 Text en Copyright © 2020, Moore et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Moore, Joel Baer, Maria R Grover, Brian E Aster, Richard H Millstein, Leah S Moxifloxacin-Induced Thrombocytopenia Mediated by Moxifloxacin-Dependent IgM and IgG Antiplatelet Antibodies: A Case Report |
title | Moxifloxacin-Induced Thrombocytopenia Mediated by Moxifloxacin-Dependent IgM and IgG Antiplatelet Antibodies: A Case Report |
title_full | Moxifloxacin-Induced Thrombocytopenia Mediated by Moxifloxacin-Dependent IgM and IgG Antiplatelet Antibodies: A Case Report |
title_fullStr | Moxifloxacin-Induced Thrombocytopenia Mediated by Moxifloxacin-Dependent IgM and IgG Antiplatelet Antibodies: A Case Report |
title_full_unstemmed | Moxifloxacin-Induced Thrombocytopenia Mediated by Moxifloxacin-Dependent IgM and IgG Antiplatelet Antibodies: A Case Report |
title_short | Moxifloxacin-Induced Thrombocytopenia Mediated by Moxifloxacin-Dependent IgM and IgG Antiplatelet Antibodies: A Case Report |
title_sort | moxifloxacin-induced thrombocytopenia mediated by moxifloxacin-dependent igm and igg antiplatelet antibodies: a case report |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571590/ https://www.ncbi.nlm.nih.gov/pubmed/33094048 http://dx.doi.org/10.7759/cureus.10507 |
work_keys_str_mv | AT moorejoel moxifloxacininducedthrombocytopeniamediatedbymoxifloxacindependentigmandiggantiplateletantibodiesacasereport AT baermariar moxifloxacininducedthrombocytopeniamediatedbymoxifloxacindependentigmandiggantiplateletantibodiesacasereport AT groverbriane moxifloxacininducedthrombocytopeniamediatedbymoxifloxacindependentigmandiggantiplateletantibodiesacasereport AT asterrichardh moxifloxacininducedthrombocytopeniamediatedbymoxifloxacindependentigmandiggantiplateletantibodiesacasereport AT millsteinleahs moxifloxacininducedthrombocytopeniamediatedbymoxifloxacindependentigmandiggantiplateletantibodiesacasereport |